Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma.

Autoria(s): Waddell, T.S.; Chau, I.; Peckitt, C.; Gonzalez, D.; Wotherspoon, A.; Patel, B.; Middleton, G.W.; Wadsley, J.; Ferry, D.; Mansoor, W.; Crosby, T.D.L.; Coxon, F.Y.; Smith, D.; Waters, J.S.; Iveson, T.; Falk, S.; Slater, S.; Okines, A.F.C.; Cunningham, D.
Data(s)

20/05/2014
Identificador

http://pure.qub.ac.uk/portal/en/publications/quality-of-life-qol-analysis-from-the-randomized-phase-iii-real3-trial-of-epirubicin-oxaliplatin-and-capecitabine-eoc-with-or-without-panitumumab-p-in-advanced-esophagogastric-adenocarcinoma(9c54d225-adbd-4299-b4db-be0a973618eb).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Waddell , T S , Chau , I , Peckitt , C , Gonzalez , D , Wotherspoon , A , Patel , B , Middleton , G W , Wadsley , J , Ferry , D , Mansoor , W , Crosby , T D L , Coxon , F Y , Smith , D , Waters , J S , Iveson , T , Falk , S , Slater , S , Okines , A F C & Cunningham , D 2014 , ' Quality of life (QoL) analysis from the randomized phase III REAL3 trial of epirubicin, oxaliplatin, and capecitabine (EOC) with or without panitumumab (P) in advanced esophagogastric adenocarcinoma. ' .
Tipo

conferenceObject
Acesso ao item digital